Paper42932101PubMed
Conductive MXene-Based Cardiac Patches: Topographical Approaches to Enhance Cardiomyocyte Function and Address Translational Engineering Challenges-A Review.
Ghanbari H and 6 others. Ann Biomed Eng, 2026.
Cite this record
ConductScience Library. Conductive MXene-Based Cardiac Patches: Topographical Approaches to Enhance Cardiomyocyte Function and Address Translational Engineering Challenges-A Review. Papers, record 42932101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42932101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Conductive MXene-Based Cardiac Patches: Topographical Approaches to Enhance Cardiomyocyte Function and Address Translational Engineering Challenges-A Review.
- Journal
- Ann Biomed Eng
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-26
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 4030028 | Kermanshah University of Medical Sciences | PubMed |
Source PubMed
References195
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38273998 | The Heart of the World. | Glob Heart | 2024 | https://conductscience.org/library/papers/38273998 | PubMed |
| 2 | 39658094 | Type 2 myocardial infarction: challenges in diagnosis and treatment. | Eur Heart J | 2025 | https://conductscience.org/library/papers/39658094 | PubMed |
| 3 | 39571837 | Advancements, challenges, and innovative strategies in cardiac rehabilitation for patients with acute myocardial infarction: A systematic review. | Curr Probl Cardiol | 2025 | https://conductscience.org/library/papers/39571837 | PubMed |
| 4 | 34968921 | Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/34968921 | PubMed |
| 5 | 31696797 | Electrochemical-Based Biosensors: New Diagnosis Platforms for Cardiovascular Disease. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/31696797 | PubMed |
| 6 | 39843488 | Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction. | NPJ Regen Med | 2025 | https://conductscience.org/library/papers/39843488 | PubMed |
| 7 | 40131159 | Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury. | JACC Basic Transl Sci | 2025 | https://conductscience.org/library/papers/40131159 | PubMed |
| 8 | 26933042 | Strategies and Challenges to Myocardial Replacement Therapy. | Stem Cells Transl Med | 2016 | https://conductscience.org/library/papers/26933042 | PubMed |
| 9 | 38885303 | Advanced Cardiac Patches for the Treatment of Myocardial Infarction. | Circulation | 2024 | https://conductscience.org/library/papers/38885303 | PubMed |
| 10 | 40123746 | MXenes as emerging materials to repair electroactive tissues and organs. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40123746 | PubMed |
| 11 | 17604100 | Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. | Biomaterials | 2007 | https://conductscience.org/library/papers/17604100 | PubMed |
| 12 | 40167360 | MXene-Incorporated Conductive Hydrogel Simulating Myocardial Microenvironment for Cardiac Repair and Functional Recovery. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/40167360 | PubMed |
| 13 | 31033484 | microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31033484 | PubMed |
| 14 | 32612263 | Next-generation stem cells - ushering in a new era of cell-based therapies. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/32612263 | PubMed |
| 15 | 31068698 | MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. | Nature | 2019 | https://conductscience.org/library/papers/31068698 | PubMed |
| 16 | 24328708 | Cardiovascular gene therapy for myocardial infarction. | Expert Opin Biol Ther | 2014 | https://conductscience.org/library/papers/24328708 | PubMed |
| 17 | 14726476 | Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. | Circ Res | 2004 | https://conductscience.org/library/papers/14726476 | PubMed |
| 18 | 33022626 | Actuation of untethered pneumatic artificial muscles and soft robots using magnetically induced liquid-to-gas phase transitions. | Sci Robot | 2020 | https://conductscience.org/library/papers/33022626 | PubMed |
| 19 | 26423725 | Clinical Trials With Mesenchymal Stem Cells: An Update. | Cell Transplant | 2016 | https://conductscience.org/library/papers/26423725 | PubMed |
| 20 | 29354322 | Local and sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischemic injury. | Nat Biomed Eng | 2017 | https://conductscience.org/library/papers/29354322 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42932101
GET https://conductscience.org/api/papers/v1/42932101/references?page=2